Serge Muyldermans,
Professor,
Vrije Universiteit
Serge Muyldermans obtained his PhD at the ‘Vrije Universiteit Brussel’, Brussels, Belgium in 1982. He was postdoc at this university at the time the functional Heavy-chain only antibodies were discovered in camelids and developed a streamlined method to identify antigen-specific, single-domain antibody fragments derived from these unique Heavy chain antibodies. This technology was used to found Ablynx NV in December 2001, a Belgian private biotech company actively developing protein therapeutics based on single variable domains or NanobodiesTM and currently employing 300 people. In 2003, he became professor at the ‘Vrije Universiteit Brussel’ where he is heading the camel-antibody engineering group in the laboratory for Cellular and Molecular Immunology.
|
|
|